Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Cutting Edge: Engineering Active IKKß in T Cells Drives Tumor Rejection.

Evaristo C, Spranger S, Barnes SE, Miller ML, Molinero LL, Locke FL, Gajewski TF, Alegre ML. Cutting Edge: Engineering Active IKKß in T Cells Drives Tumor Rejection. J Immunol. 2016 Apr 01; 196(7):2933-8.

View in: PubMed